Metraipolis › archive › dc_4ca86bb4364b

Long-Term Real-World Effectiveness and Response Trajectories of Dupilumab in Paediatric Atopic Dermatitis — Europe PMC PMID:42452324

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42452324
DOI
10.3390/jcm15134862
License (as archived)
solo-consultazione
Archived
2026-10-19T06:07:45.691Z
SHA-256 of the archived text
d1f449488cf092697b2ed4f90afa3dfe4fbafba156ef2ea33c8c6e0710a75eb5
Stable URL of this page
https://metraipolis.com/documento/dc_4ca86bb4364b

How to cite

Long-Term Real-World Effectiveness and Response Trajectories of Dupilumab in Paediatric Atopic Dermatitis — Europe PMC PMID:42452324 — Europe PMC (en), https://europepmc.org/article/MED/42452324 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ca86bb4364b (Metraipolis archive dc_4ca86bb4364b, sha256 d1f449488cf092697b2ed4f90afa3dfe4fbafba156ef2ea33c8c6e0710a75eb5)
BibTeX
@misc{dc4ca86bb4364b,
  title = {Long-Term Real-World Effectiveness and Response Trajectories of Dupilumab in Paediatric Atopic Dermatitis — Europe PMC PMID:42452324},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42452324},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ca86bb4364b; sha256 d1f449488cf092697b2ed4f90afa3dfe4fbafba156ef2ea33c8c6e0710a75eb5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42452324. Agents can read the archived copy with the MCP tool read_document.